Veriheal

JULY 16, 2020

The commission tasked with developing recommendations to improve mental health treatment for veterans concluded: Congress and the executive branch need to promote research into the therapeutic potential of cannabis and psychedelics such as psilocybin mushrooms and MDMA. Research is Limited Due to Many Obstacles.

Research and Development 95

Research and Development Clinical Trials Treatment Compliance 95

CannaMD

MARCH 24, 2021

Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis. MARIJUANA LEGALIZATION & YOUTH DRUG TREATMENT ADMISSIONS. Researchers Jeremy Mennis and Gerald J.

Treatment 104

Treatment Legalization Marijuana Research and Development 104

Cannabis Law Report

AUGUST 15, 2021

Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.

Medicine 98

Medicine Research and Development Conditions Treatment 98

MMJ Recs

MAY 9, 2024

Many veterans struggle with various physical and psychological conditions resulting from their service. In this instance, medical cannabis offers a promising alternative or complementary treatment option. These centers often cater to individuals seeking natural and non-traditional treatment options.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

OCTOBER 15, 2021

(USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung cancer and COPD as validation of PAOG’s ongoing research and development of its own respiratory disorder treatment under the name RespRx. 9,199,960).

Treatment 52

Treatment Research and Development CBD eCommerce 52

MMJ Recs

MAY 15, 2024

Anxiety is a mental health disorder that stands as one of the most prevalent and debilitating conditions affecting millions of individuals worldwide. While traditional treatment options have been the go-to for managing anxiety disorders, an alternative approach has been gaining traction in recent years: medical marijuana.

Marijuana 89

Marijuana Therapy Treatment Sleep 89

Illinois News Joint

APRIL 27, 2024

Professors and professionals in the cannabis field will deliver research and educational presentations from 12:30-4:20 p.m. Presenters include representatives from Southern Illinois University, Female Orgasm Research Institute, St. Bell teaches Cannabis Law & Entrepreneurship in SLU’s Cannabis Science and Operations program.

Research and Development 90

Research and Development Events Environment Education 90

Cannabis Law Report

MAY 26, 2022

NEO: AWKN ) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction, announced today the filing of a Patent Cooperation Treaty (PCT) application for the treatment of behavioral addictions with ketamine and ketamine-assisted psychotherapy.

Treatment 52

Treatment Research and Development Therapy Data 52

MMJ Recs

MARCH 28, 2024

Navigating the world of medical marijuana (MMJ) in Iowa can be a daunting task for patients seeking alternative treatments. With evolving laws and regulations, finding the right MMJ doctor and understanding the appointment process are crucial steps. Are you familiar with the qualifying conditions for MMJ treatment under Iowa law?

Patients 52

Patients Treatment Research and Development Therapy 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JULY 24, 2021

Argel Aguilar-Valles at Carleton University (“Carleton”) Department of Neuroscience by the Accelerate program at Mitacs for research into the anxiolytic potential of TD-010 in preclinical models of chronic anxiety and depression. Benzodiazepine Dependency.

Research and Development 98

Research and Development Treatment Therapy Media 98

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JULY 29, 2021

Ben Kaplan, CEO of Ehave, said, “We strongly believe there is a genetic predisposition to this condition and will be conducting a large-scale genetic analysis to isolate an individuals’ risk profile. Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question.

Research and Development 105

Research and Development Conditions Data Patients 105

Cannabis Law Report

AUGUST 26, 2022

Several companies are facilitating the development of this product. More research is still needed to explore this uncharted territory. CBD has been suggested to act as a treatment for sclerosis symptoms, as well as epilepsy among children. However, deeper research is needed to better understand its roles. billion in 2021.

Epilepsy 52

Epilepsy Treatment CBD Sleep 52

SpeedWeed

JUNE 2, 2021

New Hampshire Governor Chris Sununu (R) just signed a bill to expand the list of qualifying conditions for the state’s medical marijuana program. Doctors will also be able to recommend medical pot to minors with ASD, but only if they can confirm that the patient has not responded to conventional medications or treatments.

Conditions 52

Conditions Programs Research and Development Marijuana 52

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

AUGUST 3, 2021

Puerto Rico’s Governor has signed legislation into law protecting qualified medical cannabis patients from workplace discrimination. The legislation amends Puerto Rico’s medical marijuana access law so that registered patients are now classified as members of a protected class under the US territory’s employment protection laws.

Patients 105

Patients Law Research and Development Medicine 105

Veriheal

NOVEMBER 9, 2023

Traditional treatments for these conditions often involve medication, physical therapy, or more invasive interventions like surgery. This exciting development could have profound implications for how we approach managing this type of pain. However, these approaches are not always practical for everyone.

Treatment 109

Treatment Therapy Research and Development THC 109

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JUNE 30, 2021

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

JULY 27, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership. It is our hope that this study may embolden clinicians and patients to effectively partner in considering these treatments.”.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

MMJ Recs

FEBRUARY 21, 2024

This article delves into the impact of medical marijuana on various aspects of women’s well-being, addressing key areas such as reproductive health, menstrual health, mental health, hormonal balance, pain management, wellness, and specific health conditions.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

United Patients Group

OCTOBER 25, 2023

From understanding the legality of medical marijuana to its efficacy in treating various medical conditions, our guide will equip you with essential knowledge and insights on this increasingly popular treatment option. Virgin Islands permitting its use for certain medical conditions. What Conditions Can Medical Marijuana Treat?

Marijuana 91

Marijuana Patients Research and Development Edibles 91

Cannabis Law Report

DECEMBER 26, 2021

The patent relates to improved technology for detection and maintenance of the optimal therapeutic psychedelic state, which Entheon intends to study through the monitoring of electroencephalogram (EEG) biomarkers in order to optimize the treatment of neuropsychiatric conditions. ” In Vivo Toxicity Assays Completed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

MARCH 25, 2020

OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). Valencia has stewarded Sapphire in the development of its unique patent-pending pipeline. CEO Dr. Stuart Titus.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Clinical Trials 59

Cannabis Law Report

DECEMBER 21, 2021

CBG or cannabigerol is obtained from immature cannabis plants since it is not present in fully developed plants. In most fully developed cannabis plants with considerable THC and CBD concentrations, CBG levels are relatively low. Research has proven that CBG has many therapeutic qualities. Huntington’s disease.

Conditions 52

Conditions Research and Development Clinical Trials Oil 52

Cannabis Law Report

JUNE 22, 2022

Cannabis-focused pharmaceutical research and development and consumer-facing company Juva Life Inc. million, enabling it to acquire its Stockton, California, facility as well as further its clinical research on its two novel compounds. has closed a dilutive financing of $11.8 The loan bears a variable interest rate of 11.5%

Research and Development 52

Research and Development Seed-To-Sale Pharmaceutical Retail 52

United Patients Group

JULY 7, 2023

In recent years, there has been a growing interest in the use of medical cannabis to manage a variety of health conditions. Medical cannabis, also known as medical marijuana, refers to the use of the cannabis plant or its extracts to treat symptoms of disease or other medical conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Cannabis Law Report

AUGUST 2, 2021

On July 29, 2021, Puerto Rico Governor Pedro Pierluisi signed into law Act No. 42 of July 9, 2017, also known as the Act to Manage the Study, Development and Research of Cannabis for Innovation, Applicable Standards and Limits (Medicinal Cannabis Act). Your LinkedIn Connections. with the authors. 15-2021 (Act 15).

Patients 98

Patients Law Research and Development Medicine 98

Cannabis Law Report

APRIL 17, 2022

billion) annually to state revenue, Minister for Development and Investment Adonis Georgiadis said, according to greekreporter.com. Tikun Europe was established in Greece in 2018 and is a subsidiary of the Israeli Tikun Olam global player in the research and development of medical cannabis products. billion euros ($1.67

Research and Development 52

Research and Development Chronic Pain Recreational Environment 52

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Published Via JD Supra.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

MAY 12, 2022

Beckley Psytech to collaborate with Lophora on researching New Clinical Entities (NCE’s). Under the terms of the agreement Beckley Psytech will jointly fund continuing development of the Lophora pipeline and collaborate broadly on R&D. Beckley Psytech has been working diligently to build a first-class drug development capability.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Cannabis Law Report

JUNE 3, 2021

(OTCQB:KOAN), a Wellness Lifestyle cannabis holding company (“Resonate” or “the Company”), announced today it has retained the services of Colleen Quinn, an internationally celebrated clinical aromatherapist, cosmetic chemist, researcher and educator.

Research and Development 87

Research and Development Education Therapy Programs 87

Cannabis Law Report

OCTOBER 6, 2021

The lab currently holds a 56 Research Exemption for chemistry analytics on psilocybin mushrooms. Additionally, the lab has applied for a Dealer’s License and intends to eventually commercialize its psilocybin research and associated intellectual property (IP) for medical and research purposes.

Research and Development 52

Research and Development Extraction Treatment Safety 52

Puff Puff Post

JANUARY 24, 2019

“There were times when I was told you couldn’t even use ‘cannabis’ and ‘research’ in the same sentence,” he recalled. which is conducting millions of dollars worth of research on the use of cannabis to treat conditions including anxiety, insomnia and pain. The federal government is investing in marijuana research too.

Research and Development 111

Research and Development Legalization Marijuana Recreational 111

Veriheal

MAY 18, 2023

Researchers have turned to a surprising ally in this fight in recent years: cannabidiol , or CBD. Interestingly, the research demonstrated that even small doses of CBD were sufficient to produce these positive effects. This enzyme was inhibited by CBD by 50%. By 1949, this figure increased to 44% and peaked at 45% in 1954.

Cannabinoids 97

Cannabinoids CBD Research and Development Treatment 97